These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 10535423)

  • 1. Cost-effectiveness of methods to enhance sensitivity of Papanicolaou testing.
    Leidy NK; Brown R; Luce B; Sheets E
    JAMA; 1999 Oct; 282(15):1419; author reply 1420. PubMed ID: 10535423
    [No Abstract]   [Full Text] [Related]  

  • 2. Cost-effectiveness of methods to enhance sensitivity of Papanicolaou testing.
    Sedlacek TV
    JAMA; 1999 Oct; 282(15):1419-20. PubMed ID: 10535424
    [No Abstract]   [Full Text] [Related]  

  • 3. Does cost-effectiveness analysis make a difference? Lessons from Pap smears. Symposium.
    Hagen MD; Garber AM; Goldie SJ; Lafata JE; Mandelblatt J; Meltzer D; Neumann P; Siegel JE; Sox HC; Tsevat J
    Med Decis Making; 2001; 21(4):307-23. PubMed ID: 11475387
    [No Abstract]   [Full Text] [Related]  

  • 4. Rescreening of cervical Papanicolaou smears using PAPNET.
    Mango LJ; Radensky PW
    JAMA; 1998 Jun; 279(22):1786-7; author reply 1787-8. PubMed ID: 9628707
    [No Abstract]   [Full Text] [Related]  

  • 5. Rescreening of cervical Papanicolaou smears using PAPNET.
    Schechter CB
    JAMA; 1998 Jun; 279(22):1787; author reply 1787-8. PubMed ID: 9628708
    [No Abstract]   [Full Text] [Related]  

  • 6. The cost-effectiveness of cervical cancer screening for low-income elderly women.
    Mandelblatt JS; Fahs MC
    JAMA; 1988 Apr 22-29; 259(16):2409-13. PubMed ID: 3127608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of 3 methods to enhance the sensitivity of Papanicolaou testing.
    Brown AD; Garber AM
    JAMA; 1999 Jan; 281(4):347-53. PubMed ID: 9929088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Setting the target for a better cervical screening test: characteristics of a cost-effective test for cervical neoplasia screening.
    Myers ER; McCrory DC; Subramanian S; McCall N; Nanda K; Datta S; Matchar DB
    Obstet Gynecol; 2000 Nov; 96(5 Pt 1):645-52. PubMed ID: 11042294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. De novo establishment and cost-effectiveness of Papanicolaou cytology screening services in the Socialist Republic of Vietnam.
    Levin CE; Sellors JW
    Cancer; 2002 Apr; 94(8):2312-4; author reply 2314-6. PubMed ID: 12001136
    [No Abstract]   [Full Text] [Related]  

  • 10. Does the increased sensitivity of the new Papanicolaou (Pap) tests improve the cost-effectiveness of screening for cervical cancer?
    Reust CE
    J Fam Pract; 2001 Feb; 50(2):175. PubMed ID: 11219567
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of cervical cytology.
    McCrory DC; Matchar DB; Bastian L; Datta S; Hasselblad V; Hickey J; Myers E; Nanda K
    Evid Rep Technol Assess (Summ); 1999 Jan; (5):1-6. PubMed ID: 11925972
    [No Abstract]   [Full Text] [Related]  

  • 12. [Costs and problems in cervix cancer screening are considerably underestimated].
    Bistoletti P
    Lakartidningen; 2000 Aug; 97(32-33):3506-8. PubMed ID: 11037597
    [No Abstract]   [Full Text] [Related]  

  • 13. Improving the sensitivity of cervical cytology: what are the issues?
    Myers ER
    Am J Manag Care; 2000 Jul; 6(7):838-40. PubMed ID: 11067380
    [No Abstract]   [Full Text] [Related]  

  • 14. Papanicolaou testing: when does more become less?
    Sawaya GF
    Am J Med; 2005 Feb; 118(2):159-60. PubMed ID: 15694901
    [No Abstract]   [Full Text] [Related]  

  • 15. Papanicolaou screening in developing countries.
    Goldhaber-Fiebert JD
    Am J Clin Pathol; 2005 Aug; 124(2):314-5; author reply 315-6. PubMed ID: 16116686
    [No Abstract]   [Full Text] [Related]  

  • 16. The Papanicolaou test and screening for cervical cancer.
    Vasilev SA; Scott RS
    JAMA; 1997 Aug; 278(8):634. PubMed ID: 9272890
    [No Abstract]   [Full Text] [Related]  

  • 17. Pap smear provision in general practice.
    London L; Mackenzie I
    S Afr Med J; 1993 Feb; 83(2):138-9. PubMed ID: 8466577
    [No Abstract]   [Full Text] [Related]  

  • 18. Cost-effectiveness of new cytology technologies.
    Hutchinson M; Farber FL
    Am J Clin Pathol; 2000 Jan; 113(1):149-51. PubMed ID: 10631869
    [No Abstract]   [Full Text] [Related]  

  • 19. Pap smear refined.
    Oncology (Williston Park); 1997 Aug; 11(8):1125. PubMed ID: 9268975
    [No Abstract]   [Full Text] [Related]  

  • 20. Papanicolaou smears and risk of cervical neoplasia.
    Lancet; 1984 Nov; 2(8411):1099-100. PubMed ID: 6150171
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.